PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
Andrew F Teich1,2, Mikako Sakurai1,2, Mitesh Patel1,2
1Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.
Abstract:
Phosphodiesterase 5 (PDE5) is a critical component of the cGMP-PKG axis of cellular signaling in neurons, and inhibition of PDE5 has been shown to be therapeutic in a wide range of neurologic conditions in animal models. However, enthusiasm for PDE5 inhibitors in humans is limited by data suggesting that PDE5 may not exist in human neurons. Here, we first show that past attempts to quantify PDE5 mRNA were flawed due to the use of incorrect primers, and that when correct primers are used, PDE5 mRNA is detectable in human brain tissue. We then show that PDE5 protein exists in human brain by western blot and ELISA. Most importantly, we performed immunohistochemistry and demonstrate that PDE5 is present in human neurons. We hope that this work will trigger a renewed interest in the development of PDE5 inhibitors for neurologic disease.
Related Concept Videos
Neural Regulation
Excitatory and Inhibitory Effects of Neurotransmitters
Parkinson's Disease: Overview
Drugs Affecting Neurotransmitter Synthesis
Cholinergic Neurons: Neurotransmission
Drugs Affecting Neurotransmitter Release or Uptake


